49 results
8-K
EX-99.2
TARS
Tarsus Pharmaceuticals Inc
2 Aug 23
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of
4:10pm
: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526, or by email at prospectus-ny@ny.email.gs.com; BofA … Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or by email
8-K
EX-99.2
TARS
Tarsus Pharmaceuticals Inc
1 Mar 24
Tarsus Announces Proposed $100.0 Million Public Offering
5:26pm
supplement and the accompanying prospectus may also be obtained, when available, from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 … , 201 North Tryon Street, Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or by email at dg.prospectus_requests@bofa.com
8-K
EX-99.1
TARS
Tarsus Pharmaceuticals Inc
1 Mar 24
Tarsus Announces Proposed $100.0 Million Public Offering
5:26pm
and the accompanying prospectus may also be obtained, when available, from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York … , Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or by email at dg.prospectus_requests@bofa.com; Guggenheim Securities, LLC
8-K
EX-99.1
TARS
Tarsus Pharmaceuticals Inc
2 Aug 23
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of
4:10pm
: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526, or by email at prospectus-ny@ny.email.gs.com; BofA … Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or by email
8-K
TARS
Tarsus Pharmaceuticals Inc
18 Jan 24
Departure of Directors or Certain Officers
4:30pm
with the Company on February 17, 2024. The functional clinical development and medical affairs department previously led by Dr. Trevejo has been reorganized under
8-K
EX-99.1
y1z9gw
3 May 22
Tarsus Announces Proposed $50 Million Underwritten Public Offering of Shares of its Common Stock
8:34pm
8-K
EX-99.2
heza7a
3 May 22
Tarsus Announces Proposed $50 Million Underwritten Public Offering of Shares of its Common Stock
8:34pm
FWP
gbi505us
3 May 22
Free writing prospectus
6:16am
8-K
EX-1.1
8u51i
2 Aug 23
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of
4:10pm
8-K
EX-1.1
e5xlhpn jqv
3 May 22
Tarsus Announces Proposed $50 Million Underwritten Public Offering of Shares of its Common Stock
8:34pm
S-1/A
EX-1.1
rn65dik3ezdp
9 Oct 20
IPO registration (amended)
5:16pm
8-K
EX-1.1
fvd0pr2x5u9umuyqrlh
1 Mar 24
Tarsus Announces Proposed $100.0 Million Public Offering
5:26pm
ARS
kzvpw4bsxl 4gzuwc
26 Apr 23
Annual report to shareholders
4:08pm
S-3
EX-1.2
fi1w6f6wq15i5
1 Nov 21
Shelf registration
5:04pm